2001-12-01
The Lescol® Intervention Prevention Study (LIPS): A double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease
Publication
Publication
International Journal of Cardiovascular Interventions , Volume 4 - Issue 4 p. 165- 172
Additional Metadata | |
---|---|
, , , | |
doi.org/10.1080/14628840127765, hdl.handle.net/1765/72258 | |
International Journal of Cardiovascular Interventions | |
Organisation | Department of Cardiology |
Serruys, P., de Feyter, P., Benghozi, R., Hugenholtz, P., & Lesaffre, E. (2001). The Lescol® Intervention Prevention Study (LIPS): A double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease. International Journal of Cardiovascular Interventions, 4(4), 165–172. doi:10.1080/14628840127765 |